MISTY LEWIS: Open Payments
NPI 1831760255 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 17 payments from 8 companies in 2025. Trend: 2023 $481 · 2024 $1,076 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $102 |
| Alkermes, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $63 |
| ABBVIE INC. | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: FANAPT, CAPLYTA, VRAYLAR, LYBALVI, Auvelity, TRINTELLIX, REXULTI, ARISTADA.
Industry payments across GA — which companies pay providers there.
